Gene: [19q13/FRA19A] fragile site 19q13, aphidicolin type, common; — Gene: [21q22/SH3D1A] SH3 domain protein 1A; [SH3P17
]
Gene: [19q13/FRA19A] fragile site
19q13, aphidicolin type, common;
Gene: [19q13/GIPR] gastric inhibitory
polypeptide receptor; glucose-dependent insulinotropic polypeptide
receptor;
Gene: [19q13/GRIN2D] glutamate
receptor, ionotropic, N-methyl-D-aspartate 2D; [NMDAR2D
]
Gene: [19q13/HNF3G] hepatocyte
nuclear factor 3, gamma;
Gene: [19q13/HRMT1L2] HMT1 (hnRNP
methyltransferase, S. cerevisiae)-like 2; protein arginine
N-methyltransferase 1;
Gene: [19q13/IL11] interleukin 11
(adipogenesis inhibitory factor);
Gene: [19q13/KCNC2] potassium
voltage-gated channel, Shaw-related subfamily, member 2; [KV3.2
]
Gene: [19q13/KLK1] kallikrein 1
(renal/pancreas/salivary);
Gene: [19q13/KNS2B] kinesin 2, light
chain, member B; [KLC2
]
Gene: [19q13/LIPE] lipase E
(hormone-sensitive);
Gene: [19q13/MOK2] Kruppel zinc
finger protein 2;
Gene: [19q13/MST] serine/threonine
kinase, non-receptor type;
Gene: [19q13/NDUFV2P1] NADH
dehydrogenase (ubiquinone) flavoprotein 2 (24kD) pseudogene 1;
Gene: [19q13/NPAS1] neuronal PAS
domain protein 1; [MOP5
]
Gene: [19q13/NUCB1] nucleobindin 1;
[NUC
]
Gene: [19q13/OFC3] orofacial cleft
3;
Gene: [19q13/PIK3R2]
phosphatidylinositol 3-kinase, regulatory, polypeptide 2 (p85 beta); [p85b
]
Gene: [19q13/PNIA6] protein spot in
2-D gels (32kD; pI 5.7);
Gene: [19q13/PVRL2] poliovirus
receptor-like 2; poliovirus receptor related 2; [PVRR2 PRR2
]
Gene: [19q13/RDRC] RD114 virus
receptor;
Gene: [19q13/RPL13A] ribosomal
protein L13a;
Gene: [19q13/RPS19] ribosomal
protein S19;
Gene: [19q13/RRAS] related RAS viral
oncogene homolog (oncogene RRAS);
Gene: [19q13/SPIB] Spi-B
transcription factor (Spi-1/PU.1 related);
Gene: [19q13/TRSP] tRNA phosphoserine
(opal suppressor);
Gene: [19q13/UBE2L4]
ubiquitin-conjugating enzyme E2L 4;
Gene: [19q13/ZNF137] zinc finger
protein 137 (clone pHZ-30);
Gene: [19q13/ZNF13] zinc finger
protein 13 (KOX 5); [KOX5
]
Gene: [19q13/ZNF155] zinc finger
protein 155 (clone pHZ-96);
Gene: [19q13/ZNF160] zinc finger
protein 160;
Gene: [19q13/ZNF27] zinc finger
protein 27 (KOX 22); [KOX22
]
Gene: [19q13/ZNF50] zinc finger
protein 50;
Gene: [19q13/ZNF61] zinc finger
protein 61;
Gene: [19q13/ZNF83] zinc finger
protein 83 (HPF1);
Gene: [19q131/APLP1] amyloid beta
(A4) precursor-like protein 1;
Gene: [19q131/ATP4A] ATPase, H+,K+
transporting, alpha polypeptide;
Gene: [19q131/AXL] AXL transforming
sequence (a receptor tyrosine kinase); receptor tyrosine kinase
AXL;
Gene: [19q131/CAPN4] calpain, small
polypeptide (30kD; regulatory); calcium-activated neutral
proteinase;
Gene: [19q131/CD22] antigen CD22
(B-lymphocyte cell adhesion molecule);
Gene: [19q131/CEBPA] CCAAT/enhancer
binding protein (C/EBP), alpha; [CEBP
]
Gene: [19q131/CKAP1]
cytoskeleton-associated protein 1; tubulin folding cofactor B; [CG22
]
Gene: [19q131/CLC] lysopholipase of
eosinophils (Charcot-Leyden crystal protein);
Gene: [19q131/COX6B] cytochrome c
oxidase subunit VIb;
Gene: [19q131/COX7A1] cytochrome c
oxidase subunit VIIa polypeptide 1 (muscle);
Gene: [19q131/CSNU3] cystinuria,
type III;
Gene: [19q131/ECH1] enoyl-CoA
hydratase 1, peroxisomal;
Gene: [19q131/ETV2] ets
translocation variant gene 2; [ER71
]
Gene: [19q131/GPI] glucosephosphate
isomerase (phosphohexose isomerase); phosphoglucose isomerase
(phosphohexose isomerase); anemia hemolytic nonspherocytic (GPI
deficiency);
Gene: [19q131/GPR40] G
protein-coupled receptor 40;
Gene: [19q131/GPR41] G
protein-coupled receptor 41;
Gene: [19q131/GPR42] G
protein-coupled receptor 42;
Gene: [19q131/GPR43] G
protein-coupled receptor 43;
Gene: [19q131/HPN] hepsin;
Gene: [19q131/MAG] glycoprotein,
myelin associated; neuropathy due to dysmyelinogenesis; [GMA
]
Gene: [19q131/PEPD] peptidase
D;
Gene: [19q131/PLM]
phospholemman;
Gene: [19q131/PLOSL] polycystic
lipomembranous osteodysplasia with sclerosing leukoencephalopathy;
Nasu-Hakola syndrome;
Gene: [19q131/POLR2I] RNA
polymerase II (DNA directed) polypeptide I (14.5kD);
Gene: [19q131/PSMC4] proteasome
(prosome, macropain) 26S subunit, ATPase, 4 (homolog of yeast YTA2); 26S
protease regulatory subunit 6 (TAT-binding protein 7); [TBP7 S6
]
Gene: [19q131/RPMS12] ribosomal
protein, mitochondrial, S12; [RPSM12
]
Gene: [19q131/RPS16] ribosomal
protein S16;
Gene: [19q131/RYR1] ryanodine
receptor 1 (skeletal muscle; calcium release channel); Ca++ release channel
of sarcoplasmic reticulum; malignant hyperthermia susceptibility 1 (King
syndrome; MHS1; MIM:145600); central core disease of muscle (
Gene: [19q131/SCN1B] sodium
channel, voltage-gated, type I, beta polypeptide;
Gene: [19q131/TGFB1] transforming
growth factor, beta 1; [TGFB
]
Gene: [19q131/TULP2] tubby like
protein 2;
Gene: [19q131/UPK1A] uroplakin
1A;
Gene: [19q131/USF2] upstream
stimulatory factor 2, c-fos interacting;
Gene: [19q131/ZFP36] zinc finger
protein homologous to Zfp-36 in mouse; tristetraproline; [TTP
]
Gene: [19q131/ZNF146] zinc finger
protein 146;
Gene: [19q132/AD2] Alzheimer disease
2 (APOE*E4-associated, late onset);
Gene: [19q132/AKT2] murine thymoma
viral (v-akt) oncogene homolog 2; serine/threonine kinase,
Rac-beta;
Gene: [19q132/APOC1P1]
apolipoprotein C-I pseudogene 1;
Gene: [19q132/APOC1] apolipoprotein
C-I;
Gene: [19q132/APOC2] apolipoprotein
C-II (lipoprotein lipase activator); lipase D activator (apolipoprotein
C-II); hyperlipoproteinemia, type I-B (C-II anapolipoproteinemia);
Gene: [19q132/APOC4] apolipoprotein
C-IV;
Gene: [19q132/APOE] apolipoprotein
E; hyperlipoproteinemia, type III; [APOE1 HPL3
]
Gene: [19q132/ATP1A3] ATPase,
Na+,K+ transporting, alpha 3 polypeptide;
Gene: [19q132/BCKDE1A]
2-oxoisovalerate dehydrogenase (lipoamide), alpha polypeptide; branched
chain keto acid dehydrogenase E1, alpha polypeptide; maple syrup urine
disease (due to BCK-E1-alpha deficiency);
Gene: [19q132/BCL3] B-cell chronic
lymphatic leukemia 3 (B-CLL: lymphoma 3); [BCL4 D19S37
]
Gene: [19q132/BGP] biliary
glycoprotein; [BGPI
]
Gene: [19q132/CD79A] antigen CD79
alpha; immunoglobulin-associated alpha; B-lymphocyte-specific MB-1 protein
(MIM:112205); [IGA MB-1
]
Gene: [19q132/CEA] carcinoembryonic
antigen; antigen CD66E (carcinoembryonic antigen);
Gene: [19q132/CGM10]
carcinoembryonic antigen gene family member 10 (pseudogene);
Gene: [19q132/CGM11]
carcinoembryonic antigen gene family member 11 (pseudogene);
Gene: [19q132/CGM12]
carcinoembryonic antigen gene family member 12;
Gene: [19q132/CGM13]
carcinoembryonic antigen gene family member 13;
Gene: [19q132/CGM14]
carcinoembryonic antigen gene family member 14;
Gene: [19q132/CGM15]
carcinoembryonic antigen gene family member 15;
Gene: [19q132/CGM16]
carcinoembryonic antigen gene family member 16;
Gene: [19q132/CGM17]
carcinoembryonic antigen gene family member 17;
Gene: [19q132/CGM18]
carcinoembryonic antigen gene family member 18;
Gene: [19q132/CGM1] carcinoembryonic
antigen gene family member 1; antigen CD66D (carcinoembryonic antigen gene
family member 1);
Gene: [19q132/CGM2] carcinoembryonic
antigen gene family member 2;
Gene: [19q132/CGM6] carcinoembryonic
antigen gene family member 6; antigen CD66B (carcinoembryonic antigen gene
family member 6);
Gene: [19q132/CGM7] carcinoembryonic
antigen gene family member 7;
Gene: [19q132/CGM8] carcinoembryonic
antigen gene family member 8 (pseudogene);
Gene: [19q132/CGM9] carcinoembryonic
antigen gene family member 9 (pseudogene);
Gene: [19q132/CYP2A13] cytochrome
P450, subfamily IIA (phenobarbital-inducible), polypeptide 13;
Gene: [19q132/CYP2A6] cytochrome
P450, subfamily IIA (phenobarbital-inducible), polypeptide 6; coumarin
7-hydroxilase (microsomal; cytochrome P450-IIA3; MIM:122720);
Gene: [19q132/CYP2A7P1]
cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7,
pseudogene 1;
Gene: [19q132/CYP2A7P2]
cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7,
pseudogene 2;
Gene: [19q132/CYP2A7] cytochrome
P450, subfamily IIA (phenobarbital-inducible), polypeptide 7;
Gene: [19q132/CYP2B6] cytochrome
P450, subfamily IIB (phenobarbital-inducible), polypeptide 6;
Gene: [19q132/CYP2B7] cytochrome
P450, subfamily IIB (phenobarbital-inducible), polypeptide 7;
Gene: [19q132/CYP2B8] cytochrome
P450, subfamily IIB (phenobarbital-inducible), polypeptide 8;
Gene: [19q132/CYP2F1] cytochrome
P450, subfamily IIF, polypeptide 1;
Gene: [19q132/EIF5AP3] eukaryotic
translation initiation factor 5A pseudogene 3;
Gene: [19q132/GRIK5] glutamate
receptor, ionotropic, kainate 5; [GRIK2
]
Gene: [19q132/LOH19CR1] loss of
heterozygosity, 19, chromosomal region 1; anemia of Diamond and Blackfan;
[DBA
]
Gene: [19q132/LU] Lutheran blood
group; B-cell adhesion molecule (BCAM); Auberger B antigen; antigen MSK19
(gp95; monoclonal antibody F8); [BCAM MSK19
]
Gene: [19q132/NCA] non-specific cross
reacting antigen (CEA-like); [CEAL
]
Gene: [19q132/PLGAUR] plasminogen
activator, urokinase, receptor (antigen CD87); [PLAUR
]
Gene: [19q132/PSG11] pregnancy
specific beta-1-glycoprotein 11;
Gene: [19q132/PSG12] pregnancy
specific beta-1-glycoprotein 12;
Gene: [19q132/PSG13] pregnancy
specific beta-1-glycoprotein 13; [PSG14
]
Gene: [19q132/PSG1]
beta-1-glycoprotein, pregnancy specific 1; [PSBG1 SP1
]
Gene: [19q132/PSG2] pregnancy
specific beta-1-glycoprotein 2; [PSBG2
]
Gene: [19q132/PSG3] pregnancy
specific beta-1-glycoprotein 3;
Gene: [19q132/PSG4] pregnancy
specific beta-1-glycoprotein 4;
Gene: [19q132/PSG5] pregnancy
specific beta-1-glycoprotein 5;
Gene: [19q132/PSG6] pregnancy
specific beta-1-glycoprotein 6;
Gene: [19q132/PSG7] pregnancy
specific beta-1-glycoprotein 7;
Gene: [19q132/PSG8] pregnancy
specific beta-1-glycoprotein 8;
Gene: [19q132/PVR] poliovirus
receptor (sensitivity); poliomyelitis infection, susceptibility
to;
Gene: [19q132/SLC8A2] solute
carrier family 8 (sodium-calcium exchanger), member 2; [NCX2
]
Gene: [19q132/SNRPA] small nuclear
ribonucleoprotein polypeptide A (34kD); [RNPU1A
]
Gene: [19q132/XRCC1] X-ray repair
complementing defective repair in Chinese hamster cells 1; [RCC
]
Gene: [19q132/ZNF45] zinc finger
protein 45 (a Kruppel-associated box (KRAB) domain polypeptide);
Gene: [19q133/CALM3] calmodulin 3
(phosphorylase kinase, delta);
Gene: [19q133/CD33L] CD33
antigen-like;
Gene: [19q133/CD33] antigen CD33
(gp67; monoclonal antibodies My9); myeloid differentiation antigen CD33;
[GP67 MY9 p67
]
Gene: [19q133/CD37] antigen CD37
(leukocyte; homologous to OX-44 antigen of Rat);
Gene: [19q133/CGB] chorionic
gonadotropin, beta polypeptide;
Gene: [19q133/CKM] creatine kinase,
muscle form;
Gene: [19q133/CORD2] cone-rod homeo
box-containing gene; cone-rod dystrophy 2 (autosomal dominant)
(MIM:120970); amaurosis congenita of Leber III (LCA3; congenital retinal
blindness); [CRX LCA3
]
Gene: [19q133/DBP] D site of albumin
promoter binding protein;
Gene: [19q133/DMAHP] DM
locus-associated homeodomain protein;
Gene: [19q133/DMPK] myotonic
distrophy protein kinase; dystrophia myotonia;
Gene: [19q133/DMWD] dystrophia
myotonica-containing WD repeat motif; [59 DMR-N9
]
Gene: [19q133/ERCC1] excision
repair cross-complementing rodent repair deficiency, complementation group
1; [UV20
]
Gene: [19q133/ERCC2] excision
repair cross-complementing rodent repair deficiency, complementation group
2; xeroderma pigmentosum, complementation group D (MIM:278730);
trichothiodystrophy (ichthyosiform erytroderma) (MIM:601675); [XPD
TTD
Gene: [19q133/FCGRT] Fc fragment of
IgG, receptor transporter, alpha; [FcRn
]
Gene: [19q133/FLT3LG] fms-related
tyrosine kinase 3 ligand;
Gene: [19q133/FOSB] FBJ murine
osteosarcoma viral oncogene homolog B;
Gene: [19q133/FTL] ferritin, light
polypeptide; hyperferritinemia-cataract syndrome (MIM:600886);
Gene: [19q133/FUT1]
fucosyltransferase 1 (alpha (1,2) fucosyltransferase); H-deficient blood
groups expression; Bombay phenotype (hh; H-deficient blood
groups);
Gene: [19q133/FUT2]
fucosyltransferase 2 (secretor status included); secretor factor of ABH
system (ABH secretion);
Gene: [19q133/GPR4] G
protein-coupled receptor 4;
Gene: [19q133/GYS1] glycogen
synthase 1 (muscle);
Gene: [19q133/HRC] histidine-rich
calcium-binding protein;
Gene: [19q133/KCNA7] potassium
voltage-gated channel, shaker-related subfamily, member 7;
Gene: [19q133/KCNC3] potassium
voltage-gated channel, Shaw-related subfamily, member 3; [KV3.3
]
Gene: [19q133/KLK2] kallikrein 2
(prostatic);
Gene: [19q133/KLKPS]
kallikrein-like protease (prostate specific antigen);
Gene: [19q133/LHB] luteinizing
hormone, beta polypeptide (lutropin, beta chain); pseudohermaphroditism,
male, due to defective LH;
Gene: [19q133/LIG1] ligase I, DNA,
ATP-dependent;
Gene: [19q133/MER5] antigen MER5
(monoclonal antibody 2D8);
Gene: [19q133/MIA]
melanoma-inhibitory activity;
Gene: [19q133/NOVA3]
neuro-oncological ventral antigen 3 (astrocytic); [ANOVA
]
Gene: [19q133/NTF5] neurotrophin 5;
[NTF4
]
Gene: [19q133/NTF6A] neurotrophin
6, alpha; [NTF6
]
Gene: [19q133/NTF6B] neurotrophin
6, beta;
Gene: [19q133/NTF6G] neurotrophin
6, gamma;
Gene: [19q133/POLD1] polymerase
(DNA directed), delta 1, catalytic subunit (125kD);
Gene: [19q133/PPP5C] protein
phosphatase 5, catalytic subunit;
Gene: [19q133/PRSS9] protease,
serine, 9 (neurosin); protease M;
Gene: [19q133/PRSSL1] protease,
serine-like, 1 (30kD); [NES1
]
Gene: [19q133/PTGIR] prostaglandin
I2 (prostacyclin) receptor;
Gene: [19q133/RPL18] ribosomal
protein L18;
Gene: [19q133/RPS11] ribosomal
protein S11;
Gene: [19q133/SLC1A5] solute
carrier family 1 (neutral amino acid transporter), member 5;
Gene: [19q133/SNRP70] small
nuclear ribonucleoprotein 70kD polypeptide (RNP antigen); [RPU1 RNPU1Z
]
Gene: [19q133/SULT2A1]
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring,
member 1; sulfotransferase, dehydroepiandrosterone (DHEA)
-preferring;
Gene: [19q133/SULT2B1]
sulfotransferase family 2B, member 1;
Gene: [19q133/SYMPL] symplekin
(tight junction-related protein);
Gene: [19q133/TEAD2] TEA domain
family member 2; transcriptional enhancer factor 4; [TEF-4 ETEF-1
]
Gene: [19q133/THOP1] thimet
oligopeptidase 1; metallo-endopeptidase (78KD);
Gene: [19q133/UNR]
ubiquitously-expressed nuclear receptor;
Gene: [19q133/VASP]
vasodilator-stimulated phosphoprotein;
Gene: [19q134/ETFB] electron
transfer flavoprotein, beta polypeptide; glutaricaciduria IIB (ETF-beta
deficiency);
Gene: [19q134/FPR1] formyl peptide
receptor 1;
Gene: [19q134/IGHAR] Fc fragment of
IgA, receptor for; [FCAR CD89
]
Gene: [19q134/KIR2DL1] killer
cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1;
[cl-42 nkat1
]
Gene: [19q134/KIR2DL2] killer
cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2;
[cl-43 nkat6
]
Gene: [19q134/KIR2DL3] killer
cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3;
[cl-6 nkat2 nk
]
Gene: [19q134/KIR2DL4] killer
cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4;
[KIR103AS
]
Gene: [19q134/KIR2DS1] killer
cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1;
[EB6ActI
]
Gene: [19q134/KIR2DS2] killer
cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2;
[cl-49 nkat5
]
Gene: [19q134/KIR2DS3] killer
cell immunoglobulin-like receptor, two domains, short cytoplasmic tail,3;
[cl-39 nkat8
]
Gene: [19q134/KIR2DS4] killer
cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4;
[nkat7
]
Gene: [19q134/KIR2DS5] killer
cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5;
[nkat9
]
Gene: [19q134/KIR3DL1] killer
cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1;
[cl-2 cl11
]
Gene: [19q134/KIR3DL2] killer
cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;
[cl-5 nkat4
]
Gene: [19q134/KIR3DS1] killer
cell immunoglobulin-like receptor, three domains, short cytoplasmic tail,
1; [nkat10
]
Gene: [19q134/LAIR1]
leukocyte-associated immunoglobulin-like receptor 1;
Gene: [19q134/LIM2] lens intrinsic
protein 2 of lens fiber membrane (19kD);
Gene: [19q134/PEG3] paternally
expressed gene 3;
Gene: [19q134/PRKCG] protein kinase
C, gamma polypeptide;
Gene: [19q134/PTPRH] protein
tyrosine phosphatase, receptor type, H;
Gene: [19q134/RP11] retinitis
pigmentosa 11 (autosomal dominant);
Gene: [19q134/RPL28] ribosomal
protein L28;
Gene: [19q134/RPS5] ribosomal
protein S5;
Gene: [19q134/RPS9] ribosomal
protein S9;
Gene: [19q134/SYT5] synaptotagmin
5;
Gene: [19q134/TNNT1] troponin T1,
skeletal, slow; [TNT
]
Gene: [19q134/ZNF132] zinc finger
protein 132 (clone pHZ-12);
Gene: [19q134/ZNF134] zinc finger
protein 134 (clone pHZ-15);
Gene: [19q134/ZNF135] zinc finger
protein 135 (clone pHZ-17);
Gene: [19q134/ZNF154] zinc finger
protein 154 (clone pHZ-92);
Gene: [19q134/ZNF175] zinc finger
protein 175; [OTK18
]
Gene: [19q134/ZNF28] zinc finger
protein 28 (KOX 24); [KOX24
]
Gene: [19q134/ZNF30] zinc finger
protein 30 (KOX 28); [KOX28
]
Gene: [19q134/ZNF42] zinc finger
protein 42 (myeloid-specific retinoic acid-responsive);
Gene: [19^/AES] amino-terminal enhancer
of split;
Gene: [19^/BCAT2] branched chain
aminotransferase 2, mitochondrial; transaminase 2 of branched chain amino
acids (BCAA); hyperleucine-isoleucinemia (BCAA transaminase 2
deficiency?);
Gene: [19^/CLPP] ATP-dependent CLP
protease, proteolytic subunit (endopeptidase CLP);
Gene: [19^/DHPS] deoxyhypusine
synthase;
Gene: [19^/DNASE2] deoxyribonuclease
II, lysosomal;
Gene: [19^/EEC2] ectrodactyly,
ectodermal dysplasia and cleft lip/palate syndrome 2;
Gene: [19^/EEF2] eukaryotic translation
elongation factor 2; polypeptidyl-tRNA translocase;
Gene: [19^/EPD1] epiphyseal dysplasia,
multiple 1;
Gene: [19^/EYCL1] eye color 1
(green/blue); green/blue eye color; [GEY
]
Gene: [19^/GGTL2]
gamma-glutamyltransferase-like 2;
Gene: [19^/GPD2P] glycerol-3-phosphate
dehydrogenase 2 (beta, mitochondrial), processed pseudogene;
Gene: [19^/GPX4] glutathione peroxidase
4 (phospholipid hydroperoxidase);
Gene: [19^/GUSM] glucuronidase, beta
(mouse) modifier of;
Gene: [19^/HCL1] hair color 1 (brown);
[BRHC
]
Gene: [19^/HKR1] chromatin-associated
HKR-phosphoprotein 1; zinc finger oncoprotein HKR1;
Gene: [19^/HKR2] chromatin-associated
HKR-phosphoprotein 2; zinc finger oncoprotein HKR2;
Gene: [19^/HNRPM] heterogeneous
nuclear ribonucleoprotein M; RNP particle, heterogeneous nuclear, M
protein;
Gene: [19^/LGALS7] lectin,
galactoside-binding, soluble, 7; galectin 7;
Gene: [19^/M7V1] baboon M7 virus
replication factor 1;
Gene: [19^/MYBPC2] myosin-binding
protein C, fast-type;
Gene: [19^/NEUD4] neuro-d4,
neural-specific zinc finger gene; [NEURO-D4 ]
Gene: [19^/NKG7] natural killer cell
group 7 sequence; colony stimulating factor (granulocyte)-inducible 1;
[CSFI1 ]
Gene: [19^/PCSK4] proprotein
convertase subtilisin/kexin type 4;
Gene: [19^/PDE4A] phosphodiesterase
4A, cAMP-specific; (dunce (Drosophila)-homolog phosphodiesterase
E2;
Gene: [19^/PDE4C] phosphodiesterase
4C, cAMP-specific; dunce (Drosophila)-homolog phosphodiesterase
E1;
Gene: [19^/PNI1] protein spot NC22 in
2-D gels (MM 50 kD, pI 5.00);
Gene: [19^/POU2F2] POU domain, class
2, transcription factor 2; octamer-binding transcription factor 2 (B-cell
specific; lymphoid-restricted); [OTF2 OCT2 ]
Gene: [19^/RPL18A] ribosomal protein
L18a;
Gene: [19^/RPS15] ribosomal protein
S15;
Gene: [19^/TNNI3] troponin I3,
cardiac; hypertrophic cardiomyopathy type VII (CMH7); [CMH7 ]
Gene: [19^/VCB3R] Coxsackie virus B3
sensitivity; [CXB3S
]
Gene: [20p1/ENKB] prodynorphin
(preproenkephalin B); [PDYN ]
Gene: [20p1/ITPA] nucleotide
triphosphate pyrophosphatase;
Gene: [20p1/NBIA1] neurodegeneration
with brain iron accumulation 1; Hallervorden-Spatz syndrome;
Gene: [20p1/OT] oxytocin, prepro-
(neurophysin I); [NP1 OXT ]
Gene: [20p1/PCNA] cyclin
(proliferating cell nuclear antigen);
Gene: [20p1/PRNP] prion protein
(p27-30); Gerstmann-Straussler-Scheinker syndrome (GSD; MIM:137440);
Creutzfeld-Jakob disease (CJD; MIM:123400); fatal familial insomnia
(MIM:600072); scrapie (bovine spongiform encephalopathy; MIM:245300);
[
Gene: [20p1/RRBP1] ribosome binding
protein 1 (dog 180kD homolog, chicken ES/130 homolog); [ES/130 hES
]
Gene: [20p11/HNF3B] hepatocyte
nuclear factor 3, beta;
Gene: [20p112/CST1] cystatin
SN;
Gene: [20p112/CST2] cystatin SA
(cystatin S5);
Gene: [20p112/CST3] cystatin C
(amyloidosis VI, iceland type); hereditary cerebral hemorrhage with
amyloidosis, Icelandic (HCHWAI); [HCHWAI CAA ]
Gene: [20p112/CST4] cystatin S
(cystatin SA-III);
Gene: [20p112/CSTP1] cystatin
pseudogene 1;
Gene: [20p112/CSTP2] cystatin
pseudogene 2;
Gene: [20p112/CYB5P4] cytochrome
b-5 pseudogene 4;
Gene: [20p112/INSM1]
insulinoma-associated 1; zinc finger protein IA-1; [IA1 ]
Gene: [20p112/PAX1] paired box
homeotic gene 1;
Gene: [20p112/PCSK2] proprotein
convertase subtilisin/kexin-like type 2; neuroendocrine convertase 2
(proprotein convertase PC2);
Gene: [20p112/PYGB] phosphorylase,
glycogen (brain);
Gene: [20p112/SNAP]
synaptosomal-associated protein (25kD); [SNAP-25 ]
Gene: [20p112/SSTR4] somatostatin
receptor 4;
Gene: [20p112/THBD] thrombomodulin
(endothelial cell trombin receptor); [THRM TM ]
Gene: [20p112/ZNF133] zinc finger
protein 133 (clone pHZ-13);
Gene: [20p1121/CST5] cystatin
D;
Gene: [20p1123/FRA20A] fragile
site 20p11.23, folic acid type, rare;
Gene: [20p12/BMP2] bone morphogenetic
protein 2; [BMP2A ]
Gene: [20p12/CHGB] chromogranin B
(secretogranin 1); [SCG1 ]
Gene: [20p12/PLCB1] phospholipase C,
beta 1;
Gene: [20p12/PLCB4] phospholipase C,
beta 4;
Gene: [20p122/FRA20B] fragile site
20p12.2, aphidicolin type, common;
Gene: [20p122/JAG1] jagged 1;
arteriohepatic dysplasia (Alagille-Watson syndrome; MIM:118450);
cholestasis with peripheral pulmonary stenosis (MIM:118450); syndromatic
hepatic ductular hypoplasia (MIM:118450); [JAGL1 AGS
]
Gene: [20p13/ADRA1D] adrenergic,
alpha-1D-, receptor;
Gene: [20p13/ARVP] arginine
vasopressin (neurophysin II, antidiuretic hormone); diabetes insipidus
(neurohypophyseal; MIM:125700); [AVP NP2 DIH ]
Gene: [20p13/CDC25B] cell division
cycle 25B; protein tyrosine phosphatase CDC25B;
Gene: [20p13/CENPB] centromere
protein B (autoantigen B; 80kD);
Gene: [20p13/CSNK2A1] casein
kinase 2, alpha 1 polypeptide;
Gene: [20p13/FKBP1] FK506-binding
protein 1 (12kD);
Gene: [20p13/GNRH2]
gonadotropin-releasing hormone 2;
Gene: [20p13/NDUFA7] NADH
dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (14.5kD);
Gene: [20p13/PTPRA] protein tyrosine
phosphatase, receptor type, alpha;
Gene: [20p13/SN] sialoadhesin;
Gene: [20p13/SOX22] SRY
(sex-determining region Y)-box 22;
Gene: [20p13/TCF15] transcription
factor 15 (basic helix-loop-helix); [EC2
]
Gene: [20q1/AHCY]
S-adenosylhomocysteine hydrolase;
Gene: [20q1/ASIP] agouti switch
protein (cell-signaling protein);
Gene: [20q1/BPI]
bactericidal/permeability-increasing protein;
Gene: [20q1/CD40] antigen CD40 (B-cell
surface antigen);
Gene: [20q1/EPB41L1] erythrocyte
membrane protein band 4.1-like 1;
Gene: [20q1/FDXP1] ferredoxin
pseudogene 1 (adrenodoxin pseudogene 1); [ADXP1
]
Gene: [20q1/FTLL1] ferritin, light
polypeptide-like 1;
Gene: [20q1/HCK] hemopoietic cell
kinase (p59-HCK);
Gene: [20q1/HNF4A] hepatocyte nuclear
factor 4, alpha; transcription factor 14, hepatic; maturity onset diabetes
of the young 1 (MIM:125850); [TCF14 MODY1 ]
Gene: [20q1/LBP]
lipopolysaccharide-binding protein;
Gene: [20q1/MMP9] matrix
metalloproteinase 9 (gelatinase B); collagenase IVB (92kD gelatinase,
neutrophil);
Gene: [20q1/PI3] protease inhibitor 3,
skin derived (SKALP); elafin;
Gene: [20q1/PLCG1] phospholipase C,
gamma 1 (subtype 148);
Gene: [20q1/PLTP] phospholipid
transfer protein;
Gene: [20q1/RPN2] ribophorin
2;
Gene: [20q1/SDC4] syndecan 4
(amphiglycan, ryudocan);
Gene: [20q1/SEMG1] semenogelin I;
[SEMG ]
Gene: [20q1/SEMG2] semenogelin
II;
Gene: [20q1/SOX18] SRY (sex
determining region Y)-box 18;
Gene: [20q1/TGM2] transglutaminase 2
(C polypeptide, tissue type); protein-glutamine-gamma-glutamyltransferase
(transglutaminase 2);
Gene: [20q1/TGM3] transglutaminase 3
(E polypeptide); protein-glutamine-gamma-glutamyltransferase
(transglutaminase 3);
Gene: [20q1/TNNC2] troponin C2,
skeletal, fast;
Gene: [20q1/TOP1] topoisomerase (DNA)
I;
Gene: [20q1/ZNT4] zinc transporter
4;
Gene: [20q11/E2F1] E2F transcription
factor 1; retinoblastoma-binding protein 3; [RBBP3 E2F-1 ]
Gene: [20q11/FKHL18] forkhead
(Drosophila)-like 18; [freac-10
]
Gene: [20q11/ID1] inhibitor of DNA
binding 1, dominant negative helix-loop-helix protein;
Gene: [20q11/PPMD] corneal dystrophy,
posterior polymorphous; [PPCD
]
Gene: [20q112/CD39L2] CD39-like
2;
Gene: [20q112/CDAN2] congenital
dyserythropoietic anemia, type II; hereditary erythroblast multinuclearity
with positive acidified serum (HEMPAS); [CDAII HEMPAS
]
Gene: [20q112/CDMP1]
cartilage-derived morphogenic protein 1; growth differentiation factor 5;
bone morphogenetic protein 9; acromesomelic chondrodysplasia,
Hunter-Thompson type (MIM:201250); acromesomelic chondrodysplasia, Grebe
type (MIM:
Gene: [20q112/GHRF] growth hormone
releasing factor (somatocrinin); growth hormone deficiency (due to
somatocrinin defect?); [GHRH ]
Gene: [20q112/GSS] glutathione
synthetase; hereditary hemolytic anemia (due to deficiency of glutathione
synthetase; MIM:231900); 5-oxoprolinuria (due to deficiency of glutathione
synthetase; MIM:266130);
Gene: [20q112/ITGB4BP] integrin
beta 4 binding protein; eukaryotic translation initiation factor 3A;
eukaryotic translation initiation factor 6; [EIF3A EIF6 ]
Gene: [20q112/RBL1]
retinoblastoma-like 1 (p107);
Gene: [20q112/SNT1] syntrophin,
alpha (dystrophin-associated protein A1, 59kD, acidic component);
Gene: [20q112/SRC] avian sarcoma
viral oncogene homolog 1; protooncogene tyrosine protein kinase
SRC1;
Gene: [20q12/AIB1] amplified in
breast cancer 1;
Gene: [20q13/CHRNA4] cholinergic
receptor, nicotinic, alpha polypeptide 4 (neuronal); [NACHRA4 ]
Gene: [20q13/CSE1L] chromosome
segregation 1 (yeast homolog)-like; cellular apoptosis susceptibility; [CAS
]
Gene: [20q13/CTSZ] cathepsin
Z;
Gene: [20q13/EDN3] endothelin 3;
Waardenburg-Hirschsprung disease (MIM:277580); [ET3 WS4]
Gene: [20q13/EEGV1]
electro-encephalographic variant pattern 1;
Gene: [20q13/LAMA5] laminin, alpha
5;
Gene: [20q13/MC3R] melanocortin 3
receptor;
Gene: [20q13/NABC1] novel amplified
in breast cancer 1;
Gene: [20q13/NFATC2] nuclear factor
of activated T-cells, cytoplasmic 2; [NF-ATP
]
Gene: [20q13/NFIXL5] nuclear factor
I/X-like 5;
Gene: [20q13/OQTL] obesity
quantitative trait locus; obesity?;
Gene: [20q13/PCK1]
phosphoenolpyruvate carboxykinase 1 (soluble); phosphoenolpyruvate
carboxykinase deficiency;
Gene: [20q13/PTPN1] protein tyrosine
phosphatase, non-receptor type 1;
Gene: [20q13/STK6] serine/threonine
kinase 6 (Aurora/Ipl1-like);
Gene: [20q13/TPD52L2] tumor
protein D52-like 2; [D54
]
Gene: [20q13/ZNF217] zinc finger
protein 217;
Gene: [20q13/ZNF8] zinc finger
protein 8 (clone HF.18);
Gene: [20q131/CEBPB] CCAAT/enhancer
binding protein (C/EBP), beta; interleukin-6-dependent dna-binding protein;
[IL6DBP TCF5 ]
Gene: [20q131/CTSA] cathepsin A
(carboxypeptidase C); neuraminidase/beta-galactosidase protective protein;
galactosialidosis (Goldberg syndrome);
Gene: [20q131/EYA2] eyes absent
(Drosophila) homolog 2; [Eab1
]
Gene: [20q131/MYBL2] avian
myeloblastosis viral (v-myb) oncogene homolog-like 2; [BMYB ]
Gene: [20q131/STAU] staufen
(Drosophila, RNA-binding protein), human homolog of;
Gene: [20q131/YWHAB] tyrosine
3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
polypeptide; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, alpha polypeptide (phosphorylated); brain protein 14-3-3,
Gene: [20q1311/ADA] adenosine
deaminase (adenosine aminohydrolase); immune deficiency, severe combined
(due to ADA deficiency);
Gene: [20q132/GNAS1] guanine
nucleotide binding protein (G protein), alpha stimulating activity
polypeptide 1; adenylate cyclase stimulator GS, alpha-S1; Albright
hereditary osteodystrophy (MIM:103580); pseudohypoparathyroidism Ia
(Albright
Gene: [20q132/KCNB1] potassium
voltage-gated channel, Shab-related subfamily, member 1; [KV2.1 ]
Gene: [20q132/TFAP2C]
transcription factor AP-2 gamma (activating enhancer-binding protein 2
gamma);
Gene: [20q132/UBE2V1]
ubiquitin-conjugating enzyme E2 variant 1;
Gene: [20q133/COL9A3] collagen,
type IX, alpha 3 (cartilage-specific short);
Gene: [20q133/CYP24] cytochrome
P450, subfamily XXIV (vitamin D 24-hydroxylase; MIM:126065);
Gene: [20q133/GPR8] G
protein-coupled receptor 8;
Gene: [20q133/KCNQ2] potassium
voltage-gated channel, KQT-like subfamily, member 2; epilepsy, benign
neonatal 1 (MIM:121200); benign familial neonatal convulsions 1
(MIM:121200); [EBN EBN1
]
Gene: [20q133/RPS21] ribosomal
protein S21;
Gene: [20^/ADRA1A] adrenergic,
alpha-1A-, receptor; [ADRA1R ]
Gene: [20^/BAK2] BCL-2 homolog
(apoptosis regulator) BAK2; BCL2-like 7 pseudogene 1; [SYN BCL2L7P1
]
Gene: [20^/BMP7] bone morphogenetic
protein 7 (osteogenic protein 1);
Gene: [20^/CHED1] congenital
hereditary corneal edema of Maumenee (autosomal dominant);
Gene: [20^/DCE] desmosterol
delta-24-reductase;
Gene: [20^/EIF4EL2] eukaryotic
translation initiation factor 4E-like 2;
Gene: [20^/GGTL3]
gamma-glutamyltransferase-like 3;
Gene: [20^/HTL] high L-leucine
transport; [LEUT
]
Gene: [20^/MLTL4] metallothionein-like
4; [MTL4
]
Gene: [20^/MSK38] antigen MSK38
(monoclonal antibody O5);
Gene: [20^/PTGIS] prostaglandin I2
(prostacyclin) synthase; cytochrome P450, subfamily VIII (prostacyclin
synthase);
Gene: [20^/PTK6] protein tyrosine
kinase PTK6;
Gene: [20^/SNRPB] small nuclear
ribonucleoprotein polypeptides B and B1; [RNPU1B RNPSB ]
Gene: [20^/TMSL6] thymosin-like
6;
Gene: [21p111/D21Z1] satellite DNA,
alpha, aRI(680) subset;
Gene: [21p111/D21Z2] satellite DNA,
unknown class (probe pTZ18 from cos6);
Gene: [21p111/D21Z3] satellite DNA,
alpha (probe pTRA-1);
Gene: [21p111/D21Z4] satellite DNA,
alpha (probe pTRA-4);
Gene: [21p111/D21Z5] satellite DNA,
alpha (probe pTRA-2);
Gene: [21p111/D21Z6] satellite DNA,
alpha (probe pTR9H2, pTR9);
Gene: [21p111/D21Z7] satellite DNA,
alpha (probe pTRA-7);
Gene: [21p12/D21FB2S1] satellite
DNA, beta, NOR4-flanking subset 1; [DNFB2S1
]
Gene: [21p12/D21FB2S2] satellite
DNA, beta, NOR4-flanking subset 2; [DNFB2S2
]
Gene: [21p12/RNR4BAM] rDNA subset
4, BamHI-RFLP in downstream 28S rRNA gene (30-50 copies); [RNR4
]
Gene: [21p12/RNR4SN1] RNA,
ribosomal 4, 8S-1 RNA (sn-PolI; 30-50 copies); [RNR4 SNPIRNA1
]
Gene: [21p12/RNR4SN2] RNA,
ribosomal 4, 8S-2 RNA (sn-PolI; 30-50 copies); [RNR4 SNPIRNA2
]
Gene: [21p12/RNR4UA] RNA, ribosomal
4, accessory unit 5.8S rRNA (30-50 copies); [RNR4
]
Gene: [21p12/RNR4UL] RNA, ribosomal
4, large unit 28S rRNA (30-50 copies); [RNR4
]
Gene: [21p12/RNR4US] RNA, ribosomal
4, small unit 18S rRNA (30-50 copies); [RNR4
]
Gene: [21q/ACTL5] actin-like sequence
5;
Gene: [21q/SMT3H1] SMT3 (suppressor
of mif two 3, yeast) homolog 1; ubiquitin-like protein SMT3A; [SMT3A
]
Gene: [21q11/RIP140]
receptor-interacting protein 140 (nuclear factor RIP140);
Gene: [21q111/CNN2] calponin 2,
neutral, non-smooth muscle;
Gene: [21q111/STCH] stress 70
protein chaperone, microsome-associated, 60kD;
Gene: [21q2/CCT8] T-complex protein 1,
theta subunit; [CCTQ ]
Gene: [21q2/GABPA] GA-binding protein
transcription factor, alpha subunit (60kD); [E4TF1-60 ]
Gene: [21q21/PRKM10] protein
kinase, mitogen-activated 10 (MAP kinase); stress-activated protein kinase
3; c-jun N-terminal kinase 3, alpha 1 and 2;
Gene: [21q21/PRSS7] protease,
serine, 7 (enteropeptidase; enterokinase); enteropeptidase deficiency
(enterokinase deficiency);
Gene: [21q21/USH1E] Usher syndrome
1E (autosomal recessive, severe);
Gene: [21q211/APP] amyloid beta (A4)
precursor plaque core protein (cerebral vascular); protease nexin II;
Alzheimer disease 1 (MIM:104300); angiopathy, amyloid, congophylic?
(cerebral hemorrhage, Dutch type); [CVAP BAP ]
Gene: [21q213/CTBP2] C-terminal
binding protein 2;
Gene: [21q22/ATP5O] ATP synthase, H+
transporting, mitochondrial F1 complex, O subunit; oligomycin sensitivity
coffering protein;
Gene: [21q22/DSCR1] Down syndrome
candidate region 1; near DSCR proline-rich protein;
Gene: [21q22/GRIK1] glutamate
receptor, ionotropic, kainate 1; [GLUR5 ]
Gene: [21q22/IL10RB] interleukin 10
receptor, beta; cytokine receptor family II, member 4; [CRFB4 CRF2-4
]
Gene: [21q22/KCNE1] potassium
voltage-gated channel, Isk-related subfamily, member 1; minimal potassium
ion channel (minK); Jervell and Lange-Nielsen syndrome (JLNS; MIM:220400);
long QT syndrome (LQTS; LQT5); [IsK minK ]
Gene: [21q22/NDUFA6] NADH
dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (14kD, B14);
Gene: [21q22/PCP4] Purkinje cell
protein 4; [PEP-19 ]
Gene: [21q22/SH3D1A] SH3 domain
protein 1A; [SH3P17
]